Our findings that CHKα2 plays a critical role in lipolysis of lipid droplets in NSCLC suggest an attractive strategy to target the protein kinase activity of CHKα2 for NSCLC treatment. The gene discussed is WEE1; the disease is non-small cell lung carcinoma.